BioNTech SE, Mainz, Germany.
Department of Microbiology, Perelman School of Medicine, University of Pennsylvania, PA, Philadelphia, United States.
Harvard Medical School, MA, Boston, United States.
Gilead Sciences, CA, Foster City, United States.
CureVac AG, Tübingen, Germany.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, NY, United States; Moderna, MA, Cambridge, United States.
Department of Microbiology, Icahn School of Medicine at Mount Sinai, NY, United States; Global Health and Emerging Pathogens Institute, Icahn School of Medicine at Mount Sinai New York, NY, United States.
Department of Pathology and Immunology; Center for Vaccines and Immunity to Microbial Pathogens; and The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, Washington University School of Medicine, St. Louis, Missouri, USA.
Department of Medicine Solna, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
Koch Institute for Integrative Cancer Research; Department of Biological Engineering; and Department of Materials Science and Engineering, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA; Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, United States; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, MA, Cambridge, United States.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC, Melbourne, Australia; Department of Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, VIC, Melbourne, Australia.
Genentech, CA, South San Francisco, United States.
Department of Medicine, Johns Hopkins University School of Medicine, MD, Baltimore, United States.
Inserm, Center for Immunology of Viral, Hematological and Bacterial Diseases (IMVA-HB/IDMIT), Université Paris-SaclayFontenay-aux-Roses, CEA, France.
Department of Biochemistry and Institute for Protein Design, University of Washington, WA, Seattle, United States.
Human Vaccine Institute, Duke University, NC, Durham, United States.
Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, MA, Cambridge, United States.
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, Bethesda, United States.
Department of Medical Microbiology, University of Amsterdam, Amsterdam, Netherlands.
Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
Division of B Cell Immunology, German Cancer Research Center, Heidelberg, Germany.
Institute for Immunity, Transplantation and Infection; Department of Pathology; and Department of Microbiology & Immunology, Stanford University School of Medicine, Stanford University, Stanford, California, USA.
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, Bethesda, United States.
Consortium for HIV/AIDS Vaccine Development (CHAVD), Scripps Research Institute, La Jolla, CA, United States; Department of Immunology and Microbiology and IAVI Neutralizing Antibody Center, Scripps Research Institute, La Jolla, CA, United States.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC, Melbourne, Australia.
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, Bethesda, United States.
Department of Microbiology and Immunology, Peter Doherty Institute for Infection and Immunity, University of Melbourne, VIC, Melbourne, Australia.
Department of Molecular Biosciences, University of Texas at Austin, TX, Austin, United States.
Adimab, LLC, NH, United States.
Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, MD, Bethesda, United States.
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Centre for Prions and Protein Folding Diseases and Department of Biochemistry, University of Alberta, AB, Edmonton, Canada.
Texas Children's Center for Vaccine Development, Departments of Pediatrics and Molecular Virology & Microbiology, National School of Tropical Medicine, Baylor College of Medicine, TX, Houston, United States; James A Baker III Institute for Public Policy, Rice University, TX, Houston, United States; Department of Biology, Baylor University, TX, Waco, United States; Hagler Institute for Advanced Study and Scowcroft Institute of International Affairs, Bush School of Government and Public Service, Texas A&M University, College Station, TX, United States.
Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
John Wiley & Sons, 2023. Vol. 1524, nr 1, s. 65-86
antigen design, mRNA vaccines, structural vaccinology, vaccine delivery, vaccine hesitancy, vaccines